Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ERIK N WATSON

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1477577799
CMS profile
575860
Location
ATTLEBORO, MA

General Payments · PY2021–2024

$943.25

  • Reported across 48 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$726.81

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $726.81 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $120.14 6
Acerta Pharma LLC $105.25 5
Abbott Laboratories $88.43 4
Boehringer Ingelheim Pharmaceuticals, Inc. $84.55 4
Antares Pharma, Inc. $76.89 4
TOLMAR, INC. $59.66 3
Amgen Inc. $40.43 2
Axsome Therapeutics, Inc. $38.07 2
Lilly USA, LLC $36.08 2
PFIZER INC. $34.29 2
GlaxoSmithKline, LLC. $23.30 1
Radius Health, Inc. $19.72 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $59.18 4
PY2022 $31.17 2
PY2023 $126.09 6
PY2024 $726.81 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $22.04 03/06/2024 Food and Beverage Undisputed 01/23/2026 1125084287 CMS
Abbott Laboratories $23.82 04/03/2024 Food and Beverage Undisputed 01/23/2026 1125084289 CMS
Abbott Laboratories $20.07 05/22/2024 Food and Beverage Undisputed 01/23/2026 1125084291 CMS
Abbott Laboratories $22.50 11/01/2024 Food and Beverage Undisputed 01/23/2026 1125084293 CMS
Amgen Inc. $15.97 05/06/2024 Food and Beverage Undisputed 01/23/2026 1111736930 CMS
Amgen Inc. $24.46 09/12/2024 Food and Beverage Undisputed 01/23/2026 1111736932 CMS
Antares Pharma, Inc. $16.95 07/11/2024 Food and Beverage Undisputed 01/23/2026 1146491907 CMS
Antares Pharma, Inc. $20.72 08/16/2024 Food and Beverage Undisputed 01/23/2026 1146491911 CMS
Antares Pharma, Inc. $17.10 10/28/2024 Food and Beverage Undisputed 01/23/2026 1146491915 CMS
Antares Pharma, Inc. $22.12 12/12/2024 Food and Beverage Undisputed 01/23/2026 1146491919 CMS
AstraZeneca Pharmaceuticals LP $16.89 07/30/2024 Food and Beverage Undisputed 01/23/2026 1104241225 CMS
AstraZeneca Pharmaceuticals LP $23.19 09/11/2024 Food and Beverage Undisputed 01/23/2026 1104636935 CMS
AstraZeneca Pharmaceuticals LP $20.82 10/23/2024 Food and Beverage Undisputed 01/23/2026 1105869769 CMS
AstraZeneca Pharmaceuticals LP $22.74 11/12/2024 Food and Beverage Undisputed 01/23/2026 1105590444 CMS
AstraZeneca Pharmaceuticals LP $21.61 12/11/2024 Food and Beverage Undisputed 01/23/2026 1105850616 CMS
Axsome Therapeutics, Inc. $19.23 07/16/2024 Food and Beverage Undisputed 01/23/2026 1148279589 CMS
Axsome Therapeutics, Inc. $18.84 08/22/2024 Food and Beverage Undisputed 01/23/2026 1148279591 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.75 04/18/2024 Food and Beverage Undisputed 01/23/2026 1118025523 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.86 07/15/2024 Food and Beverage Undisputed 01/23/2026 1118025519 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.35 08/21/2024 Food and Beverage Undisputed 01/23/2026 1118025521 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.59 10/29/2024 Food and Beverage Undisputed 01/23/2026 1118025525 CMS
GlaxoSmithKline, LLC. $23.30 04/22/2024 Food and Beverage Undisputed 01/23/2026 1116110841 CMS
Lilly USA, LLC $17.90 03/26/2024 Food and Beverage Undisputed 01/23/2026 1134974111 CMS
Lilly USA, LLC $18.18 08/01/2024 Food and Beverage Undisputed 01/23/2026 1134968093 CMS
Novo Nordisk Inc $18.76 04/04/2024 Food and Beverage Undisputed 01/23/2026 1097428958 CMS
Novo Nordisk Inc $19.15 05/14/2024 Food and Beverage Undisputed 01/23/2026 1097536396 CMS
Novo Nordisk Inc $22.81 06/03/2024 Food and Beverage Undisputed 01/23/2026 1097450605 CMS
Novo Nordisk Inc $14.93 08/05/2024 Food and Beverage Undisputed 01/23/2026 1097467082 CMS
Novo Nordisk Inc $18.24 10/21/2024 Food and Beverage Undisputed 01/23/2026 1097186079 CMS
Novo Nordisk Inc $26.25 11/21/2024 Food and Beverage Undisputed 01/23/2026 1097281431 CMS
PFIZER INC. $20.52 05/15/2024 Food and Beverage Undisputed 01/23/2026 1131461375 CMS
PFIZER INC. $13.77 07/02/2024 Food and Beverage Undisputed 01/23/2026 1131753508 CMS
Radius Health, Inc. $19.72 10/31/2024 Food and Beverage Undisputed 01/23/2026 1089950748 CMS
Tolmar, Inc. $20.27 09/20/2024 Food and Beverage Undisputed 01/23/2026 1138714932 CMS
Tolmar, Inc. $19.85 11/18/2024 Food and Beverage Undisputed 01/23/2026 1138714934 CMS
Tolmar, Inc. $19.54 12/18/2024 Food and Beverage Undisputed 01/23/2026 1138714936 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.